Sutro Biopharma (STRO): Eigentümerstruktur
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Sutro Biopharma
Mitarbeiter 128
Handelsplatz NASDAQ
Ticker Symbol STRO
IPO Datum 2018-09-27
Adresse 111 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Webseite https://www.sutrobio.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Ms. Jane Chung R.Ph. | CEO & Director |
| 2 | Mr. Gregory K. Chow BA, CPA, MBA | Chief Financial Officer |
| 3 | Dr. Hans-Peter Gerber Ph.D. | Chief Scientific Officer |
| 4 | Dr. James R. Swartz DSc, Ph.D., Sc.D. | Founder |
| 5 | Mr. Devendra Luhar | Senior Vice President of Technical Operations |
| 6 | Mr. David Pauling J.D., M.A. | Chief Administrative Officer & General Counsel |
| 7 | Ms. Kari E. Leetch | Senior VP and Head of People & Culture |
| 8 | Mr. Jonathan Fawcett DPHIL, MBBS | VP & Head of Clinical Development |
| 9 | Ms. Regina Cheng | Vice President & Controller |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Perceptive Advisors LLC | 7,87% | 22,00 Mio. USD |
| 2 | Bvf Inc | 7,55% | 21,11 Mio. USD |
| 3 | Affinity Asset Advisors, LLC | 7,07% | 19,77 Mio. USD |
| 4 | Samsara BioCapital, LLC | 6,41% | 17,92 Mio. USD |
| 5 | Kynam Capital Management, LP | 5,26% | 14,71 Mio. USD |
| 6 | Orbimed Advisors LLC | 4,83% | 13,51 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 4,34% | 12,15 Mio. USD |
| 8 | RA Capital Management, LLC | 4,31% | 12,06 Mio. USD |
| 9 | Point72 Asset Management, L.P. | 4,17% | 11,67 Mio. USD |
| 10 | Eventide Asset Management, LLC | 3,53% | 9,87 Mio. USD |
| 11 | ADAR1 Capital Management LLC | 3,16% | 8,84 Mio. USD |
| 12 | Velan Capital Investment Management LP | 3,09% | 8,64 Mio. USD |
| 13 | Balyasny Asset Management LLC | 2,81% | 7,85 Mio. USD |
| 14 | Woodline Partners LP | 2,76% | 7,71 Mio. USD |
| 15 | UBS Group AG | 2,37% | 6,62 Mio. USD |
| 16 | Millennium Management LLC | 2,21% | 6,17 Mio. USD |
| 17 | Acadian Asset Management LLC | 2,03% | 5,66 Mio. USD |
| 18 | Merck & Co Inc | 1,64% | 4,59 Mio. USD |
| 19 | Longwood Capital Partners LLC | 1,63% | 4,56 Mio. USD |
| 20 | BlackRock Inc | 1,40% | 3,92 Mio. USD |